30.07.2014 23:08:07
|
BioMarin Pharma Q2 Loss Widens - Quick Facts
(RTTNews) - BioMarin Pharmaceutical Inc. (BMRN) Wednesday said second-quarter loss widened to $33.5 million or $0.23 per share from $21.5 million or $0.16 per share in the same period last year.
On average, 18 analysts polled by Thomson Reuters expected the company to report a loss of $0.42 per share for the quarter. Analysts' estimates typically exclude special items.
Adjusted earnings for the quarter were $10.8 million or $0.06 per share. BioMarin revenues increased 40.1 percent to $191.7 million from $136.8 million last year. Analysts expected revenues of $158.96 million.
Looking ahead to the fiscal 2014, the company currently projects revenues in the range of $745 million to $765 million, up from its prior guidance range of $650 million to $680 million. Analysts currently expect full-year revenues of $675.88 million.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Biomarin Pharmaceutical Inc.mehr Nachrichten
Analysen zu Biomarin Pharmaceutical Inc.mehr Analysen
Aktien in diesem Artikel
Biomarin Pharmaceutical Inc. | 59,00 | -6,14% |